Moberg Pharma AB (publ) (STO: MOB)

Moberg Pharma AB Revenue

Moberg Pharma AB had revenue of 97.78M SEK in the quarter ending June 30, 2024, with 27.21% growth. This brings the company's revenue in the last twelve months to 173.43M, down -8.88% year-over-year. In the year 2023, Moberg Pharma AB had annual revenue of 166.32M with 14.67% growth.

• Revenue (ttm): 173.43M
• Revenue Growth: -8.88%
• P/S Ratio: 165.80
• Revenue / Employee: 547.67K
• Employees: 9
• Market Cap: 1.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	166.32M	21.28M	14.67%
Dec 31, 2022	145.04M	3.19M	2.25%
Dec 31, 2021	141.85M	-20.60M	-12.68%
Dec 31, 2020	162.45M	36.78M	29.26%
Dec 31, 2019	125.67M	33.79M	36.78%